ImageneBio Inc (IMA) vs Rani Therapeutics Holdings, Inc. (RANI)
A side-by-side comparison of ImageneBio Inc and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMA
ImageneBio Inc
$4.69HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
RANI
Rani Therapeutics Holdings, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IMA vs RANI
growth of $100 · dividends reinvested · last 5yIMA -96.3% (-48.3%/yr)RANI -93.0% (-41.2%/yr)RANI compounded faster over this window
IMA RANI
IMA vs RANI: by the numbers
- •RANI is the larger company ($54M vs $53M market cap).
- •Both run net losses; RANI's is the smaller (-618.02% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | IMA | RANI |
|---|---|---|
| P/S ratio | N/A | 11.10 |
| P/B ratio | 0.37 | 1.38 |
Profitability
| Metric | IMA | RANI |
|---|---|---|
| Gross margin | -29.12% | 44.89% |
| Operating margin | -6056.37% | -2345.99% |
| Net margin | -5668.62% | -618.02% |
| ROE | -36.94% | -76.82% |
| ROIC | -40.53% | -63.96% |
Growth (annualized)
| Metric | IMA | RANI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.95% |
| Total return CAGR (5Y) | -50.73% | -46.70% |
Frequently asked
- How have IMA and RANI total returns compared?
- Over the past 5 years, IMA delivered -50.73% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.